🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/10/2007 | 55,07 | 55,59 | 54,63 | 55,59 | +0,69% | 1,75% | 11.615.298 |
| 30/10/2007 | 55,15 | 55,49 | 54,95 | 55,21 | +0,16% | 0,97% | 10.659.837 |
| 29/10/2007 | 55,02 | 55,51 | 54,69 | 55,12 | +0,33% | 1,49% | 13.872.481 |
| 26/10/2007 | 54,46 | 55,20 | 54,39 | 54,94 | +0,91% | 1,49% | 11.795.974 |
| 25/10/2007 | 53,63 | 54,63 | 53,41 | 54,45 | +1,53% | 2,28% | 13.313.058 |
| 24/10/2007 | 53,78 | 54,15 | 53,19 | 53,63 | -0,28% | 1,79% | 18.176.093 |
| 23/10/2007 | 52,34 | 53,85 | 51,53 | 53,78 | +3,15% | 4,43% | 19.709.841 |
| 22/10/2007 | 51,21 | 52,43 | 50,37 | 52,14 | +2,88% | 4,02% | 20.319.672 |
| 19/10/2007 | 50,68 | 51,76 | 50,52 | 50,68 | -0,52% | 2,43% | 15.173.573 |
| 18/10/2007 | 50,57 | 51,19 | 50,56 | 50,94 | -0,06% | 1,25% | 7.104.602 |
| 17/10/2007 | 50,81 | 51,05 | 50,35 | 50,97 | +0,74% | 1,37% | 11.323.745 |
| 16/10/2007 | 50,74 | 50,87 | 50,27 | 50,60 | -0,49% | 1,18% | 8.524.118 |
| 15/10/2007 | 51,53 | 51,53 | 50,66 | 50,85 | -0,41% | 1,69% | 7.411.351 |
| 12/10/2007 | 50,75 | 51,22 | 50,38 | 51,06 | +0,89% | 1,65% | 8.186.452 |
| 11/10/2007 | 50,65 | 51,23 | 50,36 | 50,61 | -0,36% | 1,71% | 7.812.630 |
| 10/10/2007 | 51,17 | 51,38 | 50,72 | 50,79 | -0,75% | 1,31% | 6.023.275 |
| 09/10/2007 | 50,77 | 51,49 | 50,65 | 51,17 | +0,90% | 1,65% | 6.659.516 |
| 08/10/2007 | 51,06 | 51,13 | 50,38 | 50,72 | -0,67% | 1,46% | 4.206.567 |
| 05/10/2007 | 50,76 | 51,56 | 50,73 | 51,06 | +1,23% | 1,64% | 9.296.074 |
| 04/10/2007 | 49,25 | 50,68 | 49,25 | 50,44 | +1,36% | 2,91% | 10.116.239 |
| 03/10/2007 | 49,22 | 50,31 | 49,08 | 49,76 | +1,03% | 2,48% | 8.664.759 |
| 02/10/2007 | 50,17 | 50,31 | 49,15 | 49,26 | -1,54% | 2,32% | 11.491.215 |
| 01/10/2007 | 49,62 | 50,28 | 49,43 | 50,03 | +1,43% | 1,71% | 11.636.887 |
| 28/09/2007 | 49,38 | 49,62 | 48,90 | 49,32 | -1,17% | 1,45% | 13.304.570 |
| 27/09/2007 | 50,11 | 50,22 | 49,54 | 49,90 | -0,57% | 1,35% | 7.114.558 |
| 26/09/2007 | 50,08 | 50,41 | 49,87 | 50,19 | +0,61% | 1,09% | 11.081.447 |
| 25/09/2007 | 49,31 | 50,20 | 49,17 | 49,89 | +1,16% | 2,09% | 11.139.402 |
| 24/09/2007 | 49,49 | 49,69 | 49,19 | 49,31 | -0,27% | 1,02% | 8.625.983 |
| 21/09/2007 | 49,06 | 49,69 | 49,03 | 49,45 | +0,86% | 1,36% | 14.918.385 |
| 20/09/2007 | 49,14 | 49,75 | 48,86 | 49,03 | -0,35% | 1,81% | 9.903.495 |